Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

NCT04211363 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

439

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Plaque Psoriasis

Interventions

DRUG: Roflumilast 0.3% cream
DRUG: Vehicle Cream

Sponsor

Arcutis Biotherapeutics, Inc.